66 research outputs found
Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: A review
The emergence and spread of drug resistant malaria represents a
considerable challenge to controlling malaria. To date, malaria control
has relied heavily on a comparatively small number of chemically
related drugs, belonging to either the quinoline or the antifolate
groups. Only recently have the artemisinin derivatives been used but
mostly in south east Asia. Experience has shown that resistance
eventually curtails the life-span of antimalarial drugs. Controlling
resistance is key to ensuring that the investment put into developing
new antimalarial drugs is not wasted. Current efforts focus on research
into new compounds with novel mechanisms of action, and on measures to
prevent or delay resistance when drugs are introduced. Drug discovery
and development are long, risky and costly ventures. Antimalarial drug
development has traditionally been slow but now various private and
public institutions are at work to discover and develop new compounds.
Today, the antimalarial development pipeline is looking reasonably
healthy. Most development relies on the quinoline, antifolate and
artemisinin compounds.There is a pressing need to have effective, easy
to use, affordable drugs that will last a long time. Drug combinations
that have independent modes of action are seen as a way of enhancing
efficacy while ensuring mutual protection against resistance. Most
research work has focused on the use of artesunate combined with
currently used standard drugs, namely, mefloquine, amodiaquine,
sulfadoxine/pyrimethamine, and chloroquine. There is clear evidence
that combinations improve efficacy without increasing toxicity.
However, the absolute cure rates that are achieved by combinations vary
widely and depend on the level of resistance of the standard drug. From
these studies, further work is underway to produce fixed dose
combinations that will be packaged in blister packs. This review will
summarise current antimalarial drug developments and outline recent
clinical research that aims to bring artemisinin based combinations to
those that need them most
What Is the Optimal Therapy for Patients with H5N1 Influenza?
Nicholas White discusses optimal dosing of oseltamivir, Robert Webster and Elena Govorkova discuss combination antiviral therapy, and Timothy Uyeki discusses clinical care of patients with H5N1
Museum and herbarium collections for biodiversity research in Angola
The importance of museum and herbarium collections is especially great
in biodiverse countries such as Angola, an importance as great as the challenges
facing the effective and sustained management of such facilities. The interface that
Angola represents between tropical humid climates and semi-desert and desert
regions creates conditions for diverse habitats with many rare and endemic species.
Museum and herbarium collections are essential foundations for scientific studies,
providing references for identifying the components of this diversity, as well as
serving as repositories of material for future study. In this review we summarise the
history and current status of museum and herbarium collections in Angola and of
information on the specimens from Angola in foreign collections. Finally, we provide
examples of the uses of museum and herbarium collections, as well as a roadmap
towards strengthening the role of collections in biodiversity knowledge
generationinfo:eu-repo/semantics/publishedVersio
Cultural drivers and health-seeking behaviours that impact on the transmission of pig-associated zoonoses in Lao People's Democratic Republic
Pig rearing is an important income source in the Lao People’s Democratic Republic (PDR), with many smallholder farmers using traditional free-range pig production systems. Despite the potentially significant health risks posed by pig production regarding pig-associated zoonoses, information on the sociocultural drivers of these zoonoses is significantly lacking. This review summarises the existing sociocultural knowledge on eight pig-associated zoonoses suspected to be endemic in Southeast Asia: brucellosis, Q fever (Coxiella burnetii), trichinellosis, hepatitis E virus, leptospirosis, Japanese encephalitis, Streptococcus suis and Taenia solium taeniasis-cysticercosis. It summarises current knowledge on these diseases grouped according to their clinical manifestations in humans to highlight the propensity for underreporting. A literature search was conducted across multiple databases for publications from 1990 to the present day related to the eight pig-associated zoonoses and the risk and impact connected with them, with Lao PDR as a case study. Many of these pig-associated zoonoses have similar presentations and are often diagnosed as clinical syndromes. Misdiagnosis and underreporting are, therefore, substantial and emphasise the need for more robust diagnostics and appropriate surveillance systems. While some reports exist in other countries in the region, information is significantly lacking in Lao PDR with existing information coming mainly from the capital, Vientiane. The disease burden imposed by these zoonoses is not only characterised by morbidity and mortality, but directly impacts on livelihoods through income reduction and production losses, and indirectly through treatment costs and lost work opportunities. Other factors crucial to understanding and controlling these diseases are the influence of ethnicity and culture on food-consumption practices, pig rearing and slaughter practices, hygiene and sanitation, health-seeking behaviours and, therefore, risk factors for disease transmission. Published information on the knowledge, attitudes and beliefs of people regarding pig zoonoses and their risk factors is also extremely limited in Lao PDR and the broader Southeast Asian region. The need for more transdisciplinary research, using a One Health approach, in order to understand the underlining social determinants of health and their impacts on health-seeking behaviours, disease transmission and, ultimately, disease reporting, cannot be more emphasized
Pulmonary manifestations of malaria: Recognition and management
Lung involvement in malaria has been recognized for more than 200 hundred years, yet our knowledge of its pathogenesis and management is limited. Pulmonary edema is the most severe form of lung involvement. Increased alveolar capillary permeability leading to intravascular fluid loss into the lungs is the main pathophysiologic mechanism. This defines malaria as another cause of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Pulmonary edema has been described most often in non-immune individuals with Plasmodium falciparum infections as part of a severe systemic illness or as the main feature of acute malaria. P. vivax and P. ovale have also rarely caused pulmonary edema. Clinically, patients usually present with acute breathlessness that can rapidly progress to respiratory failure either at disease presentation or, interestingly, after treatment when clinical improvement is taking place and the parasitemia is falling. Pregnant women are particularly prone to developing pulmonary edema. Optimal management of malaria-induced ALI/ARDS includes early recognition and diagnosis. Malaria must always be suspected in a returning traveler or a visitor from a malaria-endemic country with an acute febrile illness. Slide microscopy and/or the use of rapid antigen tests are standard diagnostic tools. Malaria must be treated with effective drugs, but current choices are few: e.g. parenteral artemisinins, intravenous quinine or quinidine (in the US only). A recent trial in adults has shown that intravenous artesunate reduces severe malaria mortality by a third compared with adults treated with intravenous quinine. Respiratory compromise should be managed on its merits and may require mechanical ventilation. Patients should be managed in an intensive care unit and particular attention should be paid to the energetic management of other severe malaria complications, notably coma and acute renal failure. ALI/ARDS may also be related to a coincidental bacterial sepsis that may not be clinically obvious. Clinicians should employ a low threshold for starting broad spectrum antibacterials in such patients, after taking pertinent microbiologic specimens. Despite optimal management, the prognosis of severe malaria with ARDS is poor. ALI/ARDS in pediatric malaria appears to be rare. However, falciparum malaria with severe metabolic acidosis or acute pulmonary edema may present with a clinical picture of pneumonia, i.e. with tachypnea, intercostal recession, wheeze or inspiratory crepitations. This results in diagnostic confusion and suboptimal treatment. Whilst this is increasingly being recognized in malaria-endemic countries, clinicians in temperate zones should be aware that malaria may be a possible cause of 'pneumonia' in a visiting or returning child. © 2006 Adis Data Information BV. All rights reserved
- …